CDTX - Watching insider transactions

NASDAQ:CDTX   Cidara Therapeutics, Inc.
Phase 2 trial results due anytime now. Watching for levels where CEO and CMO have been buying to potentially get in.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.